All about Jorge Moll, the Neurologist

Jorge Moll is a renowned Brazilian neurologist and entrepreneur. He got his medical degree from the Federal University of Rio in 1994. Four years later, Moll was through with his Neurology medical residency. He later decided to go for further education and got a Ph.D. in Experimental pathophysiology. This was obtained from the University of Sao Paulo in 2004.

He has dedicated his time doing research and trying to figure out complicated issues regarding psychology and the neural system. Jorge has made several publications like human moral cognition, the relationship the human brain shares with morals, and psychopath disorders, among others that align with academic research. Forbes has profiled him as a highly ranked person due to his vast contribution and expertise.

His passion has always been cognitive neuroscience, and he has invested a lot of his time researching about the topic in conjunction with other top researchers. Together, they have discovered the part of the brain responsible for cognition and behavior (Youtube). This has helped them in taking better care of patients with brain impairment, which is a condition that alienates its victims from the rest of the society.

Through Mr. Jorge’s research, he has been able to understand the emotions that afflict the human brain and tried to explain the sensitivity, empathy, and affection emotions via pattern analysis through fMRI neural feedback. He hopes that those findings will assist in understanding the brain signatures of such emotions. This can psychologically and clinically help people with socializing problems to trigger their pro-social brain working. However, this might prove to be a difficult task as it is not simple to control a person’s emotions or interpret them.

If there are things that intrigue Jorge Moll, they would be cognitive systems and Artificial Intelligence. He is also thrilled by the thought of how brains and machines are going to work in unity in the future. Jorge also enjoys subjects that relate to regenerative treatment and gene therapy.

One thing he has never agreed with others on is his belief that innovative science is lagging behind due to the existing career pathways and publications made by the academia and the industry itself. He believes that there is a need for fresh models that are going to address these big challenges thus, allowing high-risk projects to be carried out.